Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study

  • Vogel, A.; 
  • Chan, S.; 
  • Furuse, J.; 
  • Tak, W.; 
  • Masi, G.; 
  • 외 9명
Citations

WEB OF SCIENCE

9
제목
Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study
저자
Vogel, A.; Chan, S.; Furuse, J.; Tak, W.; Masi, G.; Varela, M.; Kim, J.; Tanasanvimon, S.; Reig, M.; Dayyani, F.; Makowsky, M.; Marcovitz, M.; Negro, A.; Abou-Alfa, G.
DOI
10.1016/j.annonc.2022.04.446
발행일
2022-06
유형
Meeting Abstract
저널명
Annals of Oncology
권
33
페이지
S380 ~ S381